Correction to: In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model.

Correction to: Lipids Health Dis 17, 24 (2018)

https://doi.org/10.1186/s12944-018-0663-2

Following the publication of the original article [1], the authors noticed an inaccuracy related to western blotting actin bands in Figs. 5 and 6.

Fig. 5

a, b Western blot relative to SOD-2 as a marker of oxidative stress. Actin is used to normalize the results. All values were expressed in the form of mean ± SD (n = 3)

Fig. 6

PPARα and PPARγ protein expression levels on HepG2 cells determined by Western blotting. Actin is used to normalize the results

In this respect, the authors apologize for uploading the western blotting (actins bands) that could be misleading. The actins obtained for the filters incubated for SOD-2 antibody were incorrectly duplicated for filters incubated with PPAR-γ. Presented here are the correct Figs. 5 and 6 with the correct actins references.